The healthcare industry is looking forward to double-digit growth, and these stocks the insiders are buying have analyst support too.
Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -2.38% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Call scheduled for Thursday, August 11th at 4:30 pm Eastern Time...
Morning Markets September S&P 500 futures (ESU22 ) this morning are down by -0.07%. Stock indexes recovered most of their overnight losses today in hopes that the pace of inflation throughout the world...
LungFit® PH received FDA approval for the treatment of term and near-term neonates with hypoxic respiratory failure on June 28, 2022 and the first phase of...
First and only nitric oxide generator and delivery system indicated for the treatment of term and near-term neonates with hypoxic respiratory failure that...
GARDEN CITY, New York, June 14, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company...
These investments seem pretty vulnerable right now.
Dr. Monson is a board-certified radiation oncologist and brings over 25 years of clinical oncology experience to Beyond Cancer. Dr. Monson is a founding...
Ms. Jones brings over 30 years of life science based financial experience to Beyond Cancer...